Irish dermatologists’ experience with JAK inhibitors in alopecia areata
Abstract
Despite a European expert consensus statement on the systemic treatment of alopecia areata, the absence of global guidelines and limited information on the long-term safety of JAKi use still poses challenges to clinicians. A cross-sectional survey was conducted to assess the use of JAKi in AA among consultant dermatologists in Ireland.
Fields of Study & Subjects
Hair Growth and Disorders
Dermatology and Skin Diseases
melanin and skin pigmentation
Publication details
- Journal / source
- Skin Health and Disease
- Volume
- 6
- Issue
- 2
- Pages
- 180–183
- Publication date
- 3 January 2026
- Language
- EN